BNET Industries
Market Cap:$26.7M
Last Fiscal Year Sales:$2.1B
- Public
- US
Dow Jones Description
Decoding nature's mysteries! Applera Corporation, based in Norwalk, CT, deals in instrument systems and associated consumable products for life science research and related applications. Its products are used in the drug, food, agriculture and chemical manufacturing industries. Applera Corporation consists of two business groups -- the Applied Biosystems group (NYSE: ABI) and the Celera Genomics group (NYSE: CRA). The Celera Genomics unit sequenced the human genome and licenses its genetic databases to biotech and drug companies for medical discoveries. Founded in 1937, the company employs about 5,400 people and has revenue of $1.8 billion. In March 2006 the company completed its acquisition of the Research Products Division of Ambion, Inc., a premium provider of innovative products for the study and analysis of ribonucleic acid (RNA), the central molecule used in gene expression and regulation, for approximately $273 million in cash.
Chairman, President & CEO
Tony L. WhiteNumber of Employees 5,160
Peer Companies
NAICS Code Analytical Laboratory Instrument Manufacturing: 334516
News & Analysis
Filter by
applera corp. - All News and Analysis
SABMiller Sees Second-half Boost
By David JonesLONDON (Reuters UK) - World No. 2 brewer SABMiller Plc SAB expects a second-half boost from currency movements and a fall in the cost of inputs such as barley after price rises and cost cuts pushed up its first-half profits.The London-based brewer of Miller Lite, Peroni and Grolsch...
Blackstone Profit Tops View; Sees More Deals Ahead
By Megan DaviesNEW YORK (Reuters) - Private equity firm Blackstone Group LP BX posted a forecast-beating quarterly profit on Friday and said it is gearing up for more deals and IPOs as the lending and equity markets recover.The company, which has immense real estate and private equity assets, has stepped...
Applied Biosystems Group F1Q09 (Qtr. End 09/30/08) Earnings Conference Call Transcript
Question-and-Answer SessionThank you, sir. This begins the question-and-answer session. [Operator Instructions]. Our first will come from the line of Quintin Lai of Robert W. Baird. Please proceed. Unidentified Analyst Good morning, guys. This is actually Mann [ph] for Quinn, congratulations on a solid quarter here. Tony L. White -...
Applera Corp.F4Q08 (Qtr. End 06/30/08) Earnings Call Transcript
Question-and-Answer Session[Operator Instructions]. Your first question comes from the line of Tycho Peterson with JPMorgan. Please proceed. Tycho Peterson - JPMorgan Hi. Good morning. A quick question I guess maybe starting out with the mass spec business, I just wanted to get a little bit more color, I appreciate...
Applera Corporation Completes Separation of its Celera Business and is Renamed Applied Biosystems Inc
FOSTER CITY, Calif. -- Applera Corporation announced today that the name of the company has been changed to Applied Biosystems Inc. to reflect the remaining business of the company following the separation of its Celera business. Effective today, Celera Corporation (NASDAQ:CRA) is an independent publicly traded company that holds the...
Applied Biosystems Group Applera Corp F3Q08 (Qtr. End 03/31/08) Earnings Call Transcript
Question-and-Answer Session[Operator Instructions] And the first question comes from the line of Doug Schenkel from Cowen and Corporation [Cowen and Company]. You may proceed. Dough Schenkel - Cowen and Company Hi, good morning guys and thanks for taking my questions. Across tools at this point I think it's fair...
Applera Corporation Files Registration Statement With Securities and Exchange Commission With Respect to the Separation of Its Celera Business
NORWALK, Conn. -- Applera Corporation today announced that its Board of Directors had authorized management to pursue a possible separation of the Celera Group (NYSE:CRA) from Applera, and had authorized the filing today of a registration statement on Form S-1 with the Securities and Exchange Commission. Completion of the proposed...
Applera Corp. F2Q08 (Qtr. End 12/31/07) Earnings Call Transcript
Question-and-Answer Session[Operator Instructions ]. Our first question comes from the line of Tycho Peterson with JPMorgan. Please proceed. Tycho Peterson - JPMorgan Hi, good morning, and thanks for taking the call. Wanted to dive a little bit more into some of the comments made about the international markets. In...
Applera Corporation F1Q08 (Qtr End 9/30/07) Earnings Call Transcript
Question-and-Answer SessionOperator Thank you sir. [Operator’s instructions.] One moment while we compile a list of questions. Our first question will come from the line of Ross Muken of Deutsche Bank, please proceed. Ross Muken – Deutsche Bank Good morning everyone. Mark P. Stevenson –...
Applied Biosystems and Eppendorf Announce Real-Time PCR Instrument Licensing Agreement
FOSTER CITY, Calif. & HAMBURG, Germany -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced it has granted a worldwide, royalty-bearing license to Eppendorf AG under a real-time thermal cycler patent rights agreement. Under the agreement, Eppendorf will have the right to manufacture and sell real-time thermal cyclers...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Dennis L. Winger | Chief Financial Officer |
| Tama Oliver | CIO & Vice President |
| Kathy Ordo | Senior Vice President |
| Kathy Ordoñez | Senior Vice President |
| Kathy P. Ordonez | Senior Vice President |
| William B. Sawch | Senior Vice President |
| Barbara J. Kerr | Vice President, Human Resources |
| Cathy Burzik | Vice President |
| Deborah A. Smeltzer | Vice President |
| Martha Trela | Vice President, Worldwide Marketing & Communications |
| Peter Dworkin | Vice President, Investor Relations & Corp Communications |
| Robert P. Ragusa | Vice President |
| Thomas P. Livingston | Vice President & Secretary |
| Ugo D. Deblasi | Vice President |
| Ana Kapor | Manager, Corp Communications |
| Joel Jung | Assistant Controller |
| Sandeep Nayyar | Assistant Controller |
| John S. Ostaszewski | Treasurer |
| Neha Desai | |
| Richard H. Ayers | Committee Member |
| Arnold J. Levine | Director |
| Carolyn W Slayman | Director |
| Jean-Luc Bélingard | Director |
| Orin R. Smith | Director |
| Robert H. Hayes | Director |
| William H. Longfield | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Tony L. White | Chairman, President & CEO |
| James R. Tobin | Board Member |
| Theodore E. Martin | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Chairman and Chief Executive Officer | Current |
| Applera Corporation | Chairman, President & CEO | Current |
| Celera Genomics | Chairman, President and Chief Executive Officer | Current |
| Celera Diagnostics, LLC | Current | |
| Centenary College | Board of Directors | Current |
| Ingersoll-Rand Company Limited | Director | Current |
| C.R. Bard, Inc. | Board of Directors | Current |
| Productivity Inc. | Director | Current |
| PerkinElmer, Inc. | Chief Executive Officer | Former |
| C.R. Bard, Inc. | Chairman, President and Chief Executive Officer, Applera Corporation | Former |
| PerkinElmer, Inc. | President | Former |
| Baxter International Inc. | Executive Vice President | Former |
| AT&T Inc. | Director | Former |
| AT&T Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President and Chief Financial Officer, Applera Corporation | Current |
| Applera Corporation | Chief Financial Officer | Current |
| PerSeptive BioSystems, Inc. | CFO & Senior Vice President | Current |
| Applera Corporation | Senior Vice President | Current |
| Celera Genomics | Current | |
| Celera Diagnostics, LLC | Current | |
| Cephalon, Inc. | Board of Directors | Current |
| Cell Genesys, Inc. | Director | Current |
| Eisenhower Fellowships | Board of Directors | Current |
| Personalized Medicine Coalition | Board of Directors | Current |
| Personalized Medicine Coalition | Member | Current |
| The Cooper Companies, Inc. | Chief Financial Officer | Former |
| Chiron | Chief Financial Officer | Former |
| Chiron | Senior Vice President, Finance and Administration | Former |
| The Cooper Companies, Inc. | NA | Former |
| Chiron | Finance | Former |
| A.P. Pharma, Inc. | Board of Directors | Former |
| Columbia University | MBA In Finance | Former |
| Columbia University | Bachelor's Degree In History | Former |
| Siena College | Bachelor’S Degree In History | Former |
| Applera Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | CIO & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Senior Vice President | Current |
| Hoffmann-La Roche Inc. | Chief Executive Officer | Former |
| Hoffmann-La Roche Inc. | President | Former |
| Celera Genomics | President | Former |
| Celera Diagnostics, LLC | President | Former |
| Hartwick College | bachelor's degree in chemistry | Former |
| Pace University | business administration | Former |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Senior Vice President | Current |
| Hoffmann-La Roche Inc. | Chief Executive Officer | Former |
| Hoffmann-La Roche Inc. | President | Former |
| Union Carbide Corporation | Marketing and Scientific | Former |
| Hartwick College | Honorary Doctorate of Sciences | Former |
| Hartwick College | B.A. Degree In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | President | Current |
| Celera Genomics Group | President | Current |
| Applera Corporation | Senior Vice President | Current |
| Celera Genomics | Senior Vice President, Applera and President, Celera Genomics and Celera Diagnostics | Current |
| Celera Genomics | CEO and Director | Current |
| Roche Molecular Systems, Inc. | Chief Executive Officer | Former |
| Applera Corporation | Chief Executive Officer | Former |
| Celera Genomics | President | Former |
| Applera Corporation | President | Former |
| Hoffmann-La Roche Inc. | President | Former |
| Roche Molecular Systems, Inc. | President | Former |
| Celera Genomics | President | Former |
| Celera Diagnostics, LLC | President | Former |
| Applied Biosystems Group | Senior Vice President, Applera Corporation, President, Celera Genomics and Celera Diagnostics | Former |
| Union Carbide Corporation | Former | |
| Roche | Former | |
| Applera Corporation | Chairman | Former |
| Hartwick College | Bachelor's Degree In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President and General Counsel, Applera Corporation | Current |
| Applera Corporation | Senior Vice President | Current |
| Applera Corporation | General Counsel | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Accenture Ltd. | management consultant | Former |
| Cummings & Lockwood | Attorney | Former |
| Applied Biosystems Group | Corporate Attorney | Former |
| Georgetown University Law Center | JD | Former |
| Princeton University | Bachelor of Science degree in engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President, Human Resources | Current |
| Celera Genomics | Vice President, Human Resources | Current |
| PerSeptive BioSystems, Inc. | Vice President, HR | Current |
| Applera Corporation | Vice President, Human Resources | Current |
| Celera Diagnostics, LLC | Current | |
| Applera Corporation | Board of Directors | Current |
| Chiron | Vice President, Human Resources | Former |
| Applied Biosystems Group | Vice President, Human Resources, Applera Corporation | Former |
| Applied Biosystems Group | Human Resources Executive | Former |
| Golden Gate University | Master’S of Business Aministration | Former |
| University of Rochester | Master’S of Education | Former |
| Wittenberg University | Bachelor’S Degree In American Studies | Former |
| Applera Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Vice President | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Ortho-Clinical Diagnostics, Inc. | president | Former |
| Applied Biosystems Group | Executive Vice President | Former |
| State University of New York at Buffalo | master's degree in mathematics | Former |
| Canisius College | bachelor's degree in mathematics | Former |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Vice President, Worldwide Marketing & Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Vice President, Investor Relations & Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Vice President & Secretary | Current |
| Applera Corporation | Secretary | Former |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Vice President | Current |
| Applera Corporation | Controller | Former |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Manager, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Celera Genomics Group | Vice President, Finance | Current |
| Applera Corporation | Assistant Controller | Current |
| Organization | Position | Status |
|---|---|---|
| PerSeptive BioSystems, Inc. | Vice President, Finance | Current |
| Applera Corporation | Assistant Controller | Current |
| American Institute of Certified Public Accountants | Board of Directors | Current |
| American Institute of Certified Public Accountants | Member | Current |
| Applied Biosystems Group | Vice President, Finance | Former |
| Corporate Finance Group | Director of Finance | Former |
| Young Corporation | Audit Manager | Former |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Treasurer | Current |
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Current | |
| Intersect Software Corporation | Board of Directors | Current |
| University of Connecticut | Masters of Science Degree In Molecular Genetics | Former |
Mr. Ayers is the retired Chairman and Chief Executive Officer of The Stanley Works, a tool and hardware manufacturer. He was an advisor to the Chairman and Chief Executive Officer of Stanley from January 1997 to October 1997 after having served as Chairman and Chief Executive Officer of Stanley from May 1989 to December 1996. Mr. Ayers is a Trustee of MassMutual Institutional Funds and MML Series Investment Fund and a director of Instron Corporation.
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Committee Member | Current |
| Celera Diagnostics, LLC | Current | |
| The Stanley Works | Chairman | Current |
| Instron Corporation | Director | Current |
| Applera Corporation | Director | Current |
| Celera Genomics | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Applied Biosystems Group | Committee Member | Current |
| Olink | Committee Member | Current |
| The Stanley Works | Chief Executive Officer | Former |
Arnold J. Levine, Ph.D., is a Professor at The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine and a Professor at the Institute for Advanced Study. From 1998 - 2002, Dr. Levine was President of Rockefeller University. Prior to joining Rockefeller University, Dr. Levine was the Harry C. Weiss Professor in the Life Sciences and Chairman of the Department of Molecular Biology at Princeton University from 1984 - 1996. Dr. Levine also serves as a Director of Theravance, Inc. and Applera Corporation, publicly traded life science companies. Dr. Levine received a B.A. in Biology from Harpur College, State University of New York at Binghamton and a Ph.D. in Microbiology from the University of Pennsylvania.
| Organization | Position | Status |
|---|---|---|
| Infinity Pharmaceuticals, Inc | Lead Research & Development Director | Current |
| Cancer Institute | Prof | Current |
| Institute for Advanced Studies | Visiting Professor | Current |
| The Cancer Institute of New Jersey | Professor | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Bg Medicine, Inc. | Co-Chairman | Current |
| Theravance, Inc. | Chairperson | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Exsar Corporation | Board of Directors | Current |
| National Academy of Sciences | Board of Directors | Current |
| Avidimer Therapeutics, Inc. | Board of Directors | Current |
| Theravance, Inc. | Board of Directors | Current |
| The Ellison Medical Foundation | Board of Directors | Current |
| Functional Genetics, Inc. | Board of Directors | Current |
| Infinity Pharmaceuticals, Inc | Board of Directors | Current |
| Applera Corporation | Director | Current |
| Theravance, Inc. | Committee Member | Current |
| The Rockefeller University | Chief Executive Officer | Former |
| The Rockefeller University | President | Former |
| Princeton University | Professor | Former |
| The Rockefeller University | Visiting Professor | Former |
| Princeton University | Chairman | Former |
| University of Pennsylvania | Ph.D. In Microbiology | Former |
| University of Pennsylvania School of Medicine | PhD In Microbiology | Former |
| State University of New York at Binghamton | B.A. | Former |
| National Academy of Sciences | member | Former |
| United States Public Health Services (USPHS) | Fellow | Former |
Dr. Slayman is the Sterling Professor of Genetics and Deputy Dean for Academic and Scientific Affairs at Yale University School of Medicine. She joined the Yale faculty in 1967. Dr. Slayman is a consultant to the National Institutes of Health, most recently having served as a member of the National Advisory General Medical Sciences Council, and a member of the Board of Overseers of Dartmouth Medical School.
| Organization | Position | Status |
|---|---|---|
| Genetics, Inc. | Sterling Professor | Current |
| Yale University School of Medicine | Deputy Dean | Current |
| National Institutes of Health | Consultant | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Applied Biosystems Group | Board of Directors | Current |
| Applera Corporation | Director | Current |
| Progress Daily | Committee Member | Current |
| Flandersbio | Committee Member | Current |
| Olink | Committee Member | Current |
| Applied Biosystems Group | Committee Member | Current |
| Yale University | Deputy Dean for Academic and Scientific Affairs | Former |
| Dartmouth Medical School | member | Former |
Mr. Tobin has served as President and Chief Executive Officer of Boston Scientific Corporation, a medical device manufacturer, since March 1999. Mr. Tobin previously served as President and Chief Executive Officer of Biogen, Inc., a biotechnology company, from 1997 to 1998 and President and Chief Operating Officer from 1994 to 1997. Prior to joining Biogen, he held various positions at Baxter International Inc., including President and Chief Operating Officer from 1992 to 1994. Mr. Tobin is also a director of Boston Scientific and Curis, Inc.
| Organization | Position | Status |
|---|---|---|
| Celera Genomics | Current | |
| Applied Biosystems Group | Co-Chair | Current |
| Applera Corporation | Board Member | Current |
| Curis, Inc. | Board of Directors | Current |
| Beth Israel Deaconess Medical Center | Board Member | Current |
| Biogen Idec, Inc. | Chief Executive Officer | Former |
| Biogen, Inc. | Chief Executive Officer | Former |
| Boston Scientific Corporation | President & Chief Executive Officer | Former |
| Biogen Idec, Inc. | President | Former |
| Biogen, Inc. | President | Former |
| Baxter International Inc. | President | Former |
| Curis, Inc. | President | Former |
| Biogen Idec, Inc. | Chief Operating Officer | Former |
| Baxter International Inc. | Chief Operating Officer | Former |
| Biogen, Inc. | Chief Operating Officer | Former |
| Baxter International Inc. | Executive Vice President | Former |
| Baxter International Inc. | Managing Director | Former |
| Guidant Corporation | Director, President & CEO | Former |
| U.S. Navy | Lieutenant | Former |
| Baxter International Inc. | NA | Former |
| Curis, Inc. | Chair | Former |
| Creative BioMolecules, Inc. | Board of Directors | Former |
| Boston Scientific Corporation | Board of Directors | Former |
| Biogen, Inc. | Director | Former |
| Applied Biosystems Group | Board of Directors | Former |
| Harvard Business School | M.B.A | Former |
| Harvard College | A.B | Former |
| Organization | Position | Status |
|---|---|---|
| Ipsen Group | Chief Executive Officer | Current |
| Applera Corporation | Director | Current |
| Exonhit Therapeutics Sa | Director | Current |
| Nicox S.A. | Director | Current |
| F. Hoffmann-La Roche Ltd. | Board of Directors | Current |
| Ipsen Group | President | Former |
| Organization | Position | Status |
|---|---|---|
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Ingersoll-Rand Company Limited | Board of Directors | Current |
| Applera Corporation | Director | Current |
| Vulcan Materials Company | Director | Current |
| BASF Catalysts LLC | Chief Executive Officer | Former |
| BASF Catalysts LLC | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Harvard Business School | Professor of Business Administration | Current |
| Celera Genomics | Current | |
| Celera Diagnostics, LLC | Current | |
| Applied Biosystems Group | Co-Chair | Current |
| Applera Corporation | Director | Current |
| Helix Technology Corporation | Director | Current |
| Applied Biosystems Group | Committee Member | Current |
| Harvard Business School | Director | Former |
| Harvard Business School | Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| Barnes Group Inc. | Chief Executive Officer | Current |
| Barnes Group Inc. | President | Current |
| Barnes Group Inc. | Group Vice President | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Ingersoll-Rand Company Limited | Board of Directors | Current |
| C.R. Bard, Inc. | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Applera Corporation | Board of Directors | Current |
| Barnes Group Inc. | Director | Former |
Array
| Organization | Position | Status |
|---|---|---|
| NYSE Group, Inc. | Current | |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Rozynski & Associates | Current | |
| Resgen Inc. | Board of Directors | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Board of Directors | Current |
| Olink | Board of Directors | Current |
| Ionsource, LLC | Board of Directors | Current |
| IDEXX Laboratories, Inc. | Board of Directors | Current |
| Industry Ventures | Board of Directors | Current |
| HCR ManorCare, Inc. | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Horizon Health Corporation | Director | Current |
| West Pharmaceutical Services, Inc. | Director | Current |
| Applera Corporation | Director | Current |
| C.R. Bard, Inc. | Director | Current |
| Microseq | Board of Directors | Current |
| Biolayer Corporation Limited | Board of Directors | Current |
| Centenary College | Trustee | Current |
| Healthios Group, LLC | Member | Current |
| C.R. Bard, Inc. | President | Former |
| Lifemark | Officer | Former |
| American Hospital Supply Corporation | Former | |
| Lifemark | Director | Former |
| Northwestern University | Graduate Degree In Management | Former |
| Drake University | Bachelor's Degrees In Business Administration | Former |
Executive News
-
Strategic Product Development Expert to Educate Utah Technology Company Executives
-
UPDATE 1-Leerink Swann raises Boston Scientific to outperform
-
Celera Corporation Reports Second Quarter 2009 Results
-
Celera Corporation Reports Second Quarter 2009 Results
Industry Transcripts by Seeking Alpha
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
-
Sunrise Senior Living Inc Q3 2009 Earnings Call Transcript
on Nov 09, 2009about SRZ
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes


